New research is shedding light on how weight-loss and diabetes medications like Ozempic, Wegovy, and Mounjaro affect not only ...

New GLP-1 weight-loss drugs may preserve muscle, protect skin, and reduce the risk of "Ozempic face." Experts explain what ...

A new daily pill may soon help people lose weight more easily and affordably than current treatments. The pill, developed by ...

Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, becoming the first publicly ...

While heart disease, diabetes and prediabetes are the most common health concerns related to obesity, many other conditions ...

Sector investors need to weigh potential cost risks with growth potential. That process starts by asking even more questions.

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

It’s just the latest landmark for Indianapolis-based Lilly, which was catapulted into the top spot as the world’s largest ...

Novo has experienced a prolonged sell.off over the last months, declining more than 65% from all-time highs. Why some kind of ...

Novo's upcoming Alzheimer's trial results will test whether Rybelsus can slow cognitive decline and reshape treatment ...

Public interest in “Ozempic face” rose sharply from 2022 to 2025, mirrored by increased searches for nonsurgical facial ...